Source:http://linkedlifedata.com/resource/pubmed/id/15488352
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2004-10-18
|
| pubmed:abstractText |
Long-term hormone replacement therapy is associated with an increased breast cancer risk. Evidence is accumulating that estradiol metabolites are involved in carcinogenesis. These metabolites may have proliferating and anti-proliferative properties. We have investigated the effect of 14 metabolites on the proliferation of human breast cancer cells and on the proliferation of human vascular endothelial cells.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0378-5122
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
49
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
235-40
|
| pubmed:meshHeading |
pubmed-meshheading:15488352-Breast Neoplasms,
pubmed-meshheading:15488352-Cell Line, Tumor,
pubmed-meshheading:15488352-Cell Proliferation,
pubmed-meshheading:15488352-Dose-Response Relationship, Drug,
pubmed-meshheading:15488352-Endothelial Cells,
pubmed-meshheading:15488352-Estradiol,
pubmed-meshheading:15488352-Estrogen Replacement Therapy,
pubmed-meshheading:15488352-Female,
pubmed-meshheading:15488352-Humans,
pubmed-meshheading:15488352-Umbilical Veins
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation.
|
| pubmed:affiliation |
Section of Endocrinology and Menopause, University Women's Hospital, Calwerstrasse 7, 72 076 Tuebingen, Germany.
|
| pubmed:publicationType |
Journal Article
|